| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
McCamish Mark Anthony is a Director at RFL with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 2 sells.
Estimated insider holdings value: $164K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 28, 2023 | AVDL Avadel Pharmaceuticals Plc | Director | Sell | 75,000 | $14.53 | $1,089,750.00 | -52.8% | +15.4% | -27.8% | |
| Aug 11, 2023 | AVDL Avadel Pharmaceuticals Plc | Director | Sell | 28,975 | $14.93 | $432,614.14 | -16.9% | -23.7% | +6.6% | |
| Sep 17, 2020 | AVDL Avadel Pharmaceuticals Plc | Director | Buy | 171,000 | $5.76 | $985,218.78 | +144.2% | - | - |